ArticleBlood2017

Momelotinib inhibits ACVR1/ALK2, decreases hepcidin production, and ameliorates anemia of chronic disease in rodents.

Malte Asshoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.